Find similar content

Source channel @githubtrending · Post #14966 · Jul 16

#other#awesome#awesome_list#c#c_plus_plus#cpp#cpp_library#cppcon#libraries#list#lists#programming_tutorial#resources You can access a vast, well-organized collection of C++ libraries, frameworks, and tools that cover almost every programming need—from standard libraries, GUI, networking, and machine learning to game engines, cryptography, and more. This curated list includes popular and high-quality options like Boost, Qt, OpenCV, and many specialized libraries for tasks such as asynchronous programming, audio processing, and serialization. Using these resources can save you time, improve code quality, and help you build efficient, robust applications by leveraging tested, peer-reviewed components instead of writing everything from scratch. It’s a one-stop reference to boost your C++ development productivity and capabilities. https://github.com/fffaraz/awesome-cpp

Hashtags

#other #awesome #awesome_list #c #c_plus_plus #cpp #cpp_library #cppcon #libraries #list #lists #programming_tutorial #resources

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment